Cellesce is a biotechnology startup based in Cardiff, United Kingdom, founded in 2013. The company focuses on the development, scale up, and manufacture of PDOs (patient-derived organoids). Their recent Seed Round investment of £1.50M on 01 June 2019 was led by Tangram Partners Limited. Cellesce's expertise in organoid technology positions them at the forefront of biotech innovation, with potential in pharmaceutical research, personalized medicine, and disease modeling.
No recent news or press coverage available for Cellesce Ltd.